3-126988609-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1

The NM_032242.4(PLXNA1):​c.16C>T​(p.Arg6Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000271 in 1,541,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R6Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

PLXNA1
NM_032242.4 missense

Scores

2
16

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 2.60

Publications

0 publications found
Variant links:
Genes affected
PLXNA1 (HGNC:9099): (plexin A1) Predicted to enable semaphorin receptor activity. Predicted to be involved in several processes, including generation of neurons; regulation of GTPase activity; and regulation of cell shape. Predicted to act upstream of or within dichotomous subdivision of terminal units involved in salivary gland branching; neuron projection morphogenesis; and regulation of smooth muscle cell migration. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
PLXNA1 Gene-Disease associations (from GenCC):
  • Dworschak-Punetha neurodevelopmental syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046779215).
BP6
Variant 3-126988609-C-T is Benign according to our data. Variant chr3-126988609-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2713615.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00133 (202/152360) while in subpopulation AFR AF = 0.00418 (174/41590). AF 95% confidence interval is 0.00368. There are 0 homozygotes in GnomAd4. There are 95 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLXNA1NM_032242.4 linkc.16C>T p.Arg6Trp missense_variant Exon 2 of 32 ENST00000393409.3 NP_115618.3 Q9UIW2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLXNA1ENST00000393409.3 linkc.16C>T p.Arg6Trp missense_variant Exon 2 of 32 1 NM_032242.4 ENSP00000377061.2 Q9UIW2
PLXNA1ENST00000684469.1 linkc.16C>T p.Arg6Trp missense_variant Exon 2 of 2 ENSP00000507976.1 A0A804HKL4

Frequencies

GnomAD3 genomes
AF:
0.00133
AC:
202
AN:
152242
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00420
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000392
AC:
66
AN:
168316
AF XY:
0.000286
show subpopulations
Gnomad AFR exome
AF:
0.00398
Gnomad AMR exome
AF:
0.000512
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000936
Gnomad OTH exome
AF:
0.000472
GnomAD4 exome
AF:
0.000155
AC:
215
AN:
1389166
Hom.:
0
Cov.:
32
AF XY:
0.000127
AC XY:
87
AN XY:
684062
show subpopulations
African (AFR)
AF:
0.00476
AC:
151
AN:
31714
American (AMR)
AF:
0.000535
AC:
19
AN:
35512
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22084
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38036
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74642
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46304
Middle Eastern (MID)
AF:
0.000184
AC:
1
AN:
5422
European-Non Finnish (NFE)
AF:
0.0000269
AC:
29
AN:
1078054
Other (OTH)
AF:
0.000261
AC:
15
AN:
57398
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00133
AC:
202
AN:
152360
Hom.:
0
Cov.:
34
AF XY:
0.00128
AC XY:
95
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00418
AC:
174
AN:
41590
American (AMR)
AF:
0.00163
AC:
25
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000429
Hom.:
0
Bravo
AF:
0.00139
ExAC
AF:
0.000310
AC:
37
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

PLXNA1-related disorder Benign:1
Jan 25, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Apr 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Benign
0.085
T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.60
T
MetaRNN
Benign
0.0047
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
2.6
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.31
N
REVEL
Benign
0.066
Sift
Uncertain
0.024
D
Sift4G
Benign
0.070
T
Vest4
0.16
MVP
0.26
MPC
0.44
ClinPred
0.024
T
GERP RS
1.4
Varity_R
0.11
gMVP
0.55
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs574438166; hg19: chr3-126707452; API